Amneal Pharmaceuticals Inc - Ordinary Shares - Class A

NYSE:AMRX   3:59:56 PM EDT
3.48
0.00 (0.00%)
Other Pre-Announcement

Amneal Reports First Quarter 2022 Financial Results

Published: 05/04/2022 10:42 GMT
Amneal Pharmaceuticals Inc - Ordinary Shares - Class A (AMRX) - Amneal Reports First Quarter 2022 Financial Results.
Q1 2022 Net Revenue of $498 Million.
Qtrly Diluted Loss per Share of $0.01.
Maintaining 2022 Full Year Outlook.
Q1 Earnings per Share View $0.13, Revenue View $504.0 Million -- Refinitiv Ibes Data (analyst estimates).
Adjusted Diluted EPS in Q1 of 2022 Was $0.12.
FY2022 Earnings per Share View $0.84, Revenue View $2.19 Billion -- Refinitiv Ibes Data (analyst estimates).